Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemant Surgical Industries has informed BSE that its Board of Directors will meet on Wednesday, November 12, 2025. The main agenda is to consider and approve the unaudited financial results for the half year ended September 30, 2025 (H1 FY26). The trading window for dealing in the company's securities has already been closed from October 1, 2025 for all designated persons and will reopen 48 hours after the results are announced. This is a standard regulatory filing under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29). No financial figures or operational details have been shared in this intimation.
This is a routine pre-results announcement and is neutral for the stock. Investors should watch the November 12 results for actual revenue, profit, and margin numbers, which could drive price action once the trading window reopens.